Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06341647
Title Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GC Cell Corporation
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
The Alfred Hosptial Melbourne Victoria 3004 Australia Details
Austin Hosptial Melbourne Victoria 3084 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field